We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year
Product News

Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year

Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year
Product News

Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Glycotope Biotechnology GmbH in Heidelberg, Germany, a full subsidiary of Berlin based Glycotope GmbH, has initiated the setup of further clean room facilities as a first step in the expansion of its GMP-production capacities.

By mid 2011, the company will thus be able to produce 4kg of recombinant antibodies per year and up to 11 kg upon completion of works towards the end of 2011. In sum, additional 1400 m² of facility and office space will be created.

The delighted Dr. Steffen Goletz, founder and CEO of Glycotope GmbH comments: “In particular the expansion of our DSP (Downstream Processing) capacities now places us among the top providers of GMP-production for recombinant proteins and in particular antibodies in Germany”.

Advertisement